Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

169 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NCT02637856

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates Cullman, Alabama, United States
  • Phoenix Neurological Associates Ltd Phoenix, Arizona, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Territory Neurology and Research Institute Tucson, Arizona, United States
View all 82 locations
View Trial Details
Completed

Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse

NCT02633033

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Territory Neurology & Research Institute Tucson, Arizona, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • Advanced Neurosciences Research Fort Collins, Colorado, United States
View all 38 locations
View Trial Details
Completed

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT02555215

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research Site Loma Linda, California, United States
  • Research Site Ghent, Belgium
  • Research Site Sofia, Bulgaria
  • Research Site Hradec Králové, Czechia
View Trial Details

Related conditions